These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 25613699)

  • 21. Relationship Between Serum microRNA155 and Telomerase Expression in Hepatocellular Carcinoma.
    Ezzat WM; Amr KS; Raouf HA; Elhosary YA; Hegazy AE; Fahim HH; Kamel RR
    Arch Med Res; 2016 Jul; 47(5):349-355. PubMed ID: 27751368
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum human telomerase reverse transcriptase messenger RNA as a novel tumor marker for hepatocellular carcinoma.
    Miura N; Maeda Y; Kanbe T; Yazama H; Takeda Y; Sato R; Tsukamoto T; Sato E; Marumoto A; Harada T; Sano A; Kishimoto Y; Hirooka Y; Murawaki Y; Hasegawa J; Shiota G
    Clin Cancer Res; 2005 May; 11(9):3205-9. PubMed ID: 15867214
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Expressions of phosphorylated-Smad2 and PTEN in hepatocellular carcinomas and adjacent liver tissues].
    Wu SK; Wang BJ; Yang Y; Tian YJ; Bao JJ; Feng XH; Yang DL
    Zhonghua Gan Zang Bing Za Zhi; 2007 Aug; 15(8):567-71. PubMed ID: 17711623
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Telomerase reverse transcriptase regulates DNMT3B expression/aberrant DNA methylation phenotype and AKT activation in hepatocellular carcinoma.
    Yu J; Yuan X; Sjöholm L; Liu T; Kong F; Ekström TJ; Björkholm M; Xu D
    Cancer Lett; 2018 Oct; 434():33-41. PubMed ID: 30017965
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The PTEN tumor suppressor inhibits telomerase activity in endometrial cancer cells by decreasing hTERT mRNA levels.
    Zhou C; Bae-Jump VL; Whang YE; Gehrig PA; Boggess JF
    Gynecol Oncol; 2006 May; 101(2):305-10. PubMed ID: 16380156
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Methylation-related silencing of p14ARF gene correlates with telomerase activity and mRNA expression of human telomerase reverse transcriptase in hepatocellular carcinoma.
    Zhang C; Guo X; Zhang L; Lu Z; Ma N; Cheng Y; Shen F; Zhang B; Wu M; Wei L
    J Surg Oncol; 2008 Nov; 98(6):462-8. PubMed ID: 18683194
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Down-regulation of tumor suppressor gene PTEN, overexpression of p53, plus high proliferating cell nuclear antigen index predict poor patient outcome of hepatocellular carcinoma after resection.
    Hu TH; Wang CC; Huang CC; Chen CL; Hung CH; Chen CH; Wang JH; Lu SN; Lee CM; Changchien CS; Tai MH
    Oncol Rep; 2007 Dec; 18(6):1417-26. PubMed ID: 17982625
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer.
    Meng F; Henson R; Wehbe-Janek H; Ghoshal K; Jacob ST; Patel T
    Gastroenterology; 2007 Aug; 133(2):647-58. PubMed ID: 17681183
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cellular distribution of telomerase reverse transcriptase in human hepatocellular carcinoma.
    Onishi T; Nouso K; Higashi T; Toshikuni N; Nakatsukasa H; Kobayashi Y; Uemura M; Yumoto E; Fujiwara K; Sato S; Nakamura S; Yokoyama J; Hanafusa T; Shiratori Y
    J Gastroenterol Hepatol; 2003 Oct; 18(10):1168-74. PubMed ID: 12974904
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overexpression of brachyury contributes to tumor metastasis by inducing epithelial-mesenchymal transition in hepatocellular carcinoma.
    Du R; Wu S; Lv X; Fang H; Wu S; Kang J
    J Exp Clin Cancer Res; 2014 Dec; 33(1):105. PubMed ID: 25499255
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Downregulation of STRAP promotes tumor growth and metastasis in hepatocellular carcinoma via reducing PTEN level.
    Wu Q; Yu S; Chen J; Li Y; Gao Y
    IUBMB Life; 2018 Feb; 70(2):120-128. PubMed ID: 29283497
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of a novel assay to quantify serum human telomerase reverse transcriptase messenger RNA and its significance as a tumor marker for hepatocellular carcinoma.
    Miura N; Maruyama S; Oyama K; Horie Y; Kohno M; Noma E; Sakaguchi S; Nagashima M; Kudo M; Kishimoto Y; Kawasaki H; Hasegawa J; Shiota G
    Oncology; 2007; 72 Suppl 1():45-51. PubMed ID: 18087181
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Loss of phosphatase and tensin homolog enhances cell invasion and migration through AKT/Sp-1 transcription factor/matrix metalloproteinase 2 activation in hepatocellular carcinoma and has clinicopathologic significance.
    Sze KM; Wong KL; Chu GK; Lee JM; Yau TO; Ng IO
    Hepatology; 2011 May; 53(5):1558-69. PubMed ID: 21520171
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic diagnostic test of hepatocellular carcinoma by telomerase catalytic subunit mRNA.
    Wada E; Hisatomi H; Moritoyo T; Kanamaru T; Hikiji K
    Oncol Rep; 1998; 5(6):1407-12. PubMed ID: 9769378
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical effects of miR-101 on prognosis of hepatocellular carcinoma and carcinogenic mechanism of anti-miR-101.
    Lv X; Li J; Yang B
    Oncol Rep; 2016 Oct; 36(4):2184-92. PubMed ID: 27498785
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression and Prognostic Role of FHIT, Fibronectin, and PTEN in Hepatocellular Carcinoma.
    Zhang MJ; Yan Q; Zhang GL; Wie YH; Yuan WB; Xu W; Huang LF
    Clin Lab; 2016 Jul; 62(7):1255-1264. PubMed ID: 28164627
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preoperative peripheral blood human telomerase reverse transcriptase mRNA concentration is not a prognostic factor for resection of hepatocellular carcinoma.
    Kim YD; Hwang S; Lee YJ; Kim KH; Ahn CS; Park KM; Moon DB; Ha TY; Song GW; Jung DH; Park SR; Hong HN; Lee SG
    Hepatogastroenterology; 2012; 59(117):1512-5. PubMed ID: 22683968
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of hepatitis B virus X protein on human telomerase reverse transcriptase expression and activity in hepatoma cells.
    Zhang X; Dong N; Zhang H; You J; Wang H; Ye L
    J Lab Clin Med; 2005 Feb; 145(2):98-104. PubMed ID: 15746653
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sensitive detection of human telomerase reverse transcriptase mRNA in the serum of patients with hepatocellular carcinoma.
    Miura N; Shiota G; Nakagawa T; Maeda Y; Sano A; Marumoto A; Kishimoto Y; Murawaki Y; Hasegawa J
    Oncology; 2003; 64(4):430-4. PubMed ID: 12759542
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The alteration of PTEN tumor suppressor expression and its association with the histopathological features of human primary hepatocellular carcinoma.
    Wan XW; Jiang M; Cao HF; He YQ; Liu SQ; Qiu XH; Wu MC; Wang HY
    J Cancer Res Clin Oncol; 2003 Feb; 129(2):100-6. PubMed ID: 12669234
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.